# Hologic (HOLX) Forecast Calculator

Interactive five-year financial forecast and DCF for Hologic. Adjust revenue growth, margins, capex, and WACC to update revenue, free cash flow, and enterprise value.

- Canonical: https://finamodel.com/companies/hologic/forecast
- Industry: Healthcare
- Forecast start year: 2026

## Historical data

| Year | Revenue | Free cash flow | EBITDA | Net income |
|---:|---:|---:|---:|---:|
| 2021 | 3367300000 | 592500000 | 339300000 | -203600000 |
| 2022 | 3776400000 | 798300000 | 1481000000 | 1115200000 |
| 2023 | 5632300000 | 2212100000 | 2887200000 | 1871500000 |
| 2024 | 4862800000 | 2055100000 | 2070300000 | 1302000000 |
| 2025 | 4030400000 | 959400000 | 991800000 | 456000000 |

## Frequently asked questions

### What is Hologic's core business and how does it generate revenue?

Hologic is a leading medical technology company focused on women's health, developing diagnostic products, medical imaging systems, and surgical products. The company employs a "razor and blades" model, placing capital equipment to generate highly profitable, recurring revenue from assays, disposables, and service contracts.

### Which business segments are the primary revenue drivers for Hologic?

Hologic's primary revenue drivers are its Diagnostics segment, accounting for approximately 44% of revenue, and its Breast Health segment, contributing about 40%. These segments leverage capital equipment placements to secure recurring revenue streams from related assays, disposables, and service contracts.

### What is the assumed revenue growth rate in the Hologic financial model?

The Hologic financial model incorporates a Revenue_Growth assumption of approximately 4.6% for its forecast horizon. This growth rate is a critical input for projecting the company's future financial performance from FY2026 through FY2030.

### What is the main objective of the Hologic financial model regarding valuation?

The primary objective of the Hologic financial model is to conduct a standalone discounted cash flow (DCF) valuation of the company. This analysis aims to assess the fairness of the pending $79 per share acquisition offer from Blackstone and TPG.

### Is an Excel financial model available for Hologic (HOLX) and what is its forecast period?

Yes, an Excel financial model for Hologic (HOLX) is available for download. This general corporate model provides financial forecasts for the company from FY2026 through FY2030.

### How is capital expenditure treated in Hologic's financial model?

In Hologic's financial model, capital expenditure is assumed to be approximately 2.03% of revenue. A significant portion, about 60%, is growth capex, primarily allocated to placing new Panther diagnostic instruments at customer sites to drive future recurring assay revenue.